Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker LARK
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | Patrick L. Alexander Director | LARK Landmark Bancorp Inc. | Sale | 204 | $32.50 | $6,630 Sale | Form 4 ↗ |
| Nov 5, 2026 | Patrick L. Alexander Director | LARK Landmark Bancorp Inc. | Sale | 350 | $32.50 | $11.4K Sale | Form 4 ↗ |
| Nov 4, 2026 | Patrick L. Alexander Director | LARK Landmark Bancorp Inc. | Sale | 3,018 | $32.50 | $98.1K Sale | Form 4 ↗ |
| Nov 3, 2026 | Patrick L. Alexander Director | LARK Landmark Bancorp Inc. | Sale | 2 | $32.50 | $65 Sale | Form 4 ↗ |
| Nov 2, 2026 | Patrick L. Alexander Director | LARK Landmark Bancorp Inc. | Sale | 1,000 | $32.50 | $32.5K Sale | Form 4 ↗ |
| Oct 30, 2026 | Jim Lewis Director | LARK Landmark Bancorp Inc. | Sale | 550 | $32.16 | $17.7K Sale | Form 4 ↗ |
| Oct 29, 2026 | Jim Lewis Director | LARK Landmark Bancorp Inc. | Sale | 26 | $32.48 | $844 Sale | Form 4 ↗ |
| Oct 27, 2026 | Jim Lewis Director | LARK Landmark Bancorp Inc. | Sale | 183 | $32.40 | $5,929 Sale | Form 4 ↗ |
| Sep 15, 2026 | Jim Lewis Director | LARK Landmark Bancorp Inc. | Sale | 400 | $32.92 | $13.2K Sale | Form 4 ↗ |
| Sep 14, 2026 | Patrick L. Alexander Director | LARK Landmark Bancorp Inc. | Sale | 226 | $32.50 | $7,345 Sale | Form 4 ↗ |
| Aug 7, 2026 | Mark J. Kohlrus Director | LARK Landmark Bancorp Inc. | Buy | 799 | $31.83 | $25.4K Buy | Form 4 ↗ |
| Aug 6, 2026 | Mark J. Kohlrus Director | LARK Landmark Bancorp Inc. | Buy | 201 | $31.50 | $6,332 Buy | Form 4 ↗ |
| Jun 12, 2026 | Jim Lewis Director | LARK Landmark Bancorp Inc. | Sale | 900 | $29.48 | $26.5K Sale | Form 4 ↗ |
| Jun 11, 2026 | Jim Lewis Director | LARK Landmark Bancorp Inc. | Sale | 367 | $29.08 | $10.7K Sale | Form 4 ↗ |
| Jun 10, 2026 | Jim Lewis Director | LARK Landmark Bancorp Inc. | Sale | 98 | $29.10 | $2,852 Sale | Form 4 ↗ |
| Jun 9, 2026 | Jim Lewis Director | LARK Landmark Bancorp Inc. | Sale | 25 | $29.00 | $725 Sale | Form 4 ↗ |
| Jun 2, 2026 | Patrick L. Alexander Director | LARK Landmark Bancorp Inc. | Sale | 700 | $28.50 | $19.9K Sale | Form 4 ↗ |
| May 29, 2026 | Patrick L. Alexander Director | LARK Landmark Bancorp Inc. | Sale | 3,300 | $28.51 | $94.1K Sale | Form 4 ↗ |
| May 28, 2026 | Patrick L. Alexander Director | LARK Landmark Bancorp Inc. | Sale | 1,482 | $28.50 | $42.2K Sale | Form 4 ↗ |
| May 28, 2026 | Jim Lewis Director | LARK Landmark Bancorp Inc. | Sale | 800 | $28.14 | $22.5K Sale | Form 4 ↗ |
| May 26, 2026 | Angela S. Hurt Director | LARK Landmark Bancorp Inc. | Buy | 235 | $27.91 | $6,559 Buy | Form 4 ↗ |
| Dec 11, 2025 | Patrick L. Alexander Director | LARK Landmark Bancorp Inc. | Sale | 6,500 | $28.50 | $185.3K Sale | Form 4 ↗ |
| Dec 11, 2025 | Patrick L. Alexander Director | LARK Landmark Bancorp Inc. | Sale | 1,500 | $28.56 | $42.8K Sale | Form 4 ↗ |
| Dec 11, 2025 | Patrick L. Alexander Director | LARK Landmark Bancorp Inc. | Sale | 1,000 | $28.77 | $28.8K Sale | Form 4 ↗ |
| May 20, 2025 | Michael E. Scheopner Director | LARK Landmark Bancorp Inc. | Sale | 916 | $29.80 | $27.3K Sale | Form 4 ↗ |
| May 19, 2025 | Michael E. Scheopner Director | LARK Landmark Bancorp Inc. | Sale | 130 | $29.80 | $3,874 Sale | Form 4 ↗ |
| May 15, 2025 | Michael E. Scheopner Director | LARK Landmark Bancorp Inc. | Sale | 476 | $30.00 | $14.3K Sale | Form 4 ↗ |
| May 15, 2025 | Michael E. Scheopner Director | LARK Landmark Bancorp Inc. | Sale | 454 | $29.80 | $13.5K Sale | Form 4 ↗ |
| May 12, 2025 | Michael E. Scheopner Director | LARK Landmark Bancorp Inc. | Sale | 30 | $29.62 | $889 Sale | Form 4 ↗ |
| May 12, 2025 | Michael E. Scheopner Director | LARK Landmark Bancorp Inc. | Sale | 100 | $29.57 | $2,957 Sale | Form 4 ↗ |
| May 12, 2025 | Michael E. Scheopner Director | LARK Landmark Bancorp Inc. | Sale | 70 | $29.56 | $2,069 Sale | Form 4 ↗ |
| May 12, 2025 | Michael E. Scheopner Director | LARK Landmark Bancorp Inc. | Sale | 824 | $29.50 | $24.3K Sale | Form 4 ↗ |
| May 5, 2025 | Michael E. Scheopner Director | LARK Landmark Bancorp Inc. | Sale | 4,500 | $30.05 | $135.2K Sale | Form 4 ↗ |
| May 5, 2025 | Michael E. Scheopner Director | LARK Landmark Bancorp Inc. | Sale | 3,000 | $30.04 | $90.1K Sale | Form 4 ↗ |
| May 5, 2025 | Michael E. Scheopner Director | LARK Landmark Bancorp Inc. | Sale | 6,558 | $30.02 | $196.9K Sale | Form 4 ↗ |
| May 5, 2025 | Michael E. Scheopner Director | LARK Landmark Bancorp Inc. | Sale | 27,000 | $30.00 | $810.0K Sale | Form 4 ↗ |
| May 5, 2025 | Patrick L. Alexander Director | LARK Landmark Bancorp Inc. | Sale | 600 | $30.16 | $18.1K Sale | Form 4 ↗ |
| May 5, 2025 | Patrick L. Alexander Director | LARK Landmark Bancorp Inc. | Sale | 3,000 | $30.42 | $91.3K Sale | Form 4 ↗ |
| Mar 6, 2025 | Mark J. Kohlrus Director | LARK Landmark Bancorp Inc. | Buy | 150 | $22.95 | $3,443 Buy | Form 4 ↗ |
| Mar 5, 2025 | Mark J. Kohlrus Director | LARK Landmark Bancorp Inc. | Buy | 150 | $22.75 | $3,413 Buy | Form 4 ↗ |
| Mar 4, 2025 | Mark J. Kohlrus Director | LARK Landmark Bancorp Inc. | Buy | 129 | $23.04 | $2,972 Buy | Form 4 ↗ |
| Mar 3, 2025 | Mark J. Kohlrus Director | LARK Landmark Bancorp Inc. | Buy | 200 | $23.79 | $4,758 Buy | Form 4 ↗ |
| Feb 28, 2025 | Mark J. Kohlrus Director | LARK Landmark Bancorp Inc. | Buy | 200 | $23.75 | $4,750 Buy | Form 4 ↗ |
| Feb 26, 2025 | Mark J. Kohlrus Director | LARK Landmark Bancorp Inc. | Buy | 200 | $22.50 | $4,500 Buy | Form 4 ↗ |
| Feb 25, 2025 | Mark J. Kohlrus Director | LARK Landmark Bancorp Inc. | Buy | 200 | $23.49 | $4,698 Buy | Form 4 ↗ |
| Feb 24, 2025 | Mark J. Kohlrus Director | LARK Landmark Bancorp Inc. | Buy | 200 | $24,545.00 | $4.9M Buy | Form 4 ↗ |
| Feb 20, 2025 | Mark J. Kohlrus Director | LARK Landmark Bancorp Inc. | Buy | 200 | $25.00 | $5,000 Buy | Form 4 ↗ |
| Feb 19, 2025 | Mark J. Kohlrus Director | LARK Landmark Bancorp Inc. | Buy | 200 | $25.09 | $5,018 Buy | Form 4 ↗ |
| Feb 18, 2025 | Mark J. Kohlrus Director | LARK Landmark Bancorp Inc. | Buy | 200 | $26.00 | $5,200 Buy | Form 4 ↗ |
| Feb 13, 2025 | Michael E. Scheopner Director | LARK Landmark Bancorp Inc. | Sale | 9,895 | $25.01 | $247.5K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 9:00 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances